CD64 binding potential does not translate into enhanced therapeutic efficacy for anti-IL-23 antibodies under physiologically relevant conditions

Joel F. Cohen-Solal, Calvin S. Pohl, Sheila M. Cummings, Jeremy P. Gygi, Zhaleh Safikhani, Brigitte Bartocha, Christopher D. Buckley, Yongli Dong, Killian Eyerich, Samuel D. Karsen, Grace R. Lynch, Michael Macoritto, Pierre A. Morisset, Ornella D. Nelson, Timothy Radstake, Florian Rieder, Jocelyn Rivas, John P. Savaryn, Kathleen M. Smith, Madison Stulir, Carmin Szynal, Casey Tylek, Geertruida M. Veldman, Laura G. Wasserman, Susan Westmoreland, Neha Chaudhary, Matthew M. Staron

Open source

DOI: 10.1186/s10020-026-01462-z
Published: 2026-03-28
Container: Molecular Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s10020-026-01462-z,
  title = {CD64 binding potential does not translate into enhanced therapeutic efficacy for anti-IL-23 antibodies under physiologically relevant conditions},
  author = {Joel F. Cohen-Solal and Calvin S. Pohl and Sheila M. Cummings and Jeremy P. Gygi and Zhaleh Safikhani and Brigitte Bartocha and Christopher D. Buckley and Yongli Dong and Killian Eyerich and Samuel D. Karsen and Grace R. Lynch and Michael Macoritto and Pierre A. Morisset and Ornella D. Nelson and Timothy Radstake and Florian Rieder and Jocelyn Rivas and John P. Savaryn and Kathleen M. Smith and Madison Stulir and Carmin Szynal and Casey Tylek and Geertruida M. Veldman and Laura G. Wasserman and Susan Westmoreland and Neha Chaudhary and Matthew M. Staron},
  year = {2026},
  journal = {Molecular Medicine},
  doi = {10.1186/s10020-026-01462-z},
  url = {https://doi.org/10.1186/s10020-026-01462-z}
}

RIS

TY  - JOUR
TI  - CD64 binding potential does not translate into enhanced therapeutic efficacy for anti-IL-23 antibodies under physiologically relevant conditions
AU  - Joel F. Cohen-Solal
AU  - Calvin S. Pohl
AU  - Sheila M. Cummings
AU  - Jeremy P. Gygi
AU  - Zhaleh Safikhani
AU  - Brigitte Bartocha
AU  - Christopher D. Buckley
AU  - Yongli Dong
AU  - Killian Eyerich
AU  - Samuel D. Karsen
AU  - Grace R. Lynch
AU  - Michael Macoritto
AU  - Pierre A. Morisset
AU  - Ornella D. Nelson
AU  - Timothy Radstake
AU  - Florian Rieder
AU  - Jocelyn Rivas
AU  - John P. Savaryn
AU  - Kathleen M. Smith
AU  - Madison Stulir
AU  - Carmin Szynal
AU  - Casey Tylek
AU  - Geertruida M. Veldman
AU  - Laura G. Wasserman
AU  - Susan Westmoreland
AU  - Neha Chaudhary
AU  - Matthew M. Staron
PY  - 2026
JO  - Molecular Medicine
DO  - 10.1186/s10020-026-01462-z
UR  - https://doi.org/10.1186/s10020-026-01462-z
ER  -

APA

Cohen-Solal, J. F., Pohl, C. S., Cummings, S. M., Gygi, J. P., Safikhani, Z., Bartocha, B., Buckley, C. D., Dong, Y., Eyerich, K., Karsen, S. D., Lynch, G. R., Macoritto, M., Morisset, P. A., Nelson, O. D., Radstake, T., Rieder, F., Rivas, J., Savaryn, J. P., Smith, K. M., Stulir, M., Szynal, C., Tylek, C., Veldman, G. M., Wasserman, L. G., Westmoreland, S., Chaudhary, N., & Staron, M. M. (2026). CD64 binding potential does not translate into enhanced therapeutic efficacy for anti-IL-23 antibodies under physiologically relevant conditions. Molecular Medicine. https://doi.org/10.1186/s10020-026-01462-z

Source records

crossref · retrieved 2026-09-26T05:12:22.989Z